Unknown PHASE4 INTERVENTIONAL 2-arm NCT03270735

A Clinical Study to Evaluate the Efficacy and Safety of Hemocoagulase Injection

A Multi-centre, Randomised, Double Blind, Placebo Controlled Clinical Study to Evaluate the Efficacy and Safety of Snake Venom Thrombin Injection in the Treatment of Moderate to Severe Hemoptysis

Sponsor: Lee's Pharmaceutical Limited

Conditions Hemoptysis

Interventions Placebo Snake venom thrombin (Treatment)

Updated 6 times since 2017 Last updated: Aug 31, 2017 Started: Jun 6, 2017 Primary completion: Jun 30, 2018 Completion: Dec 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Hemoptysis and is currently ongoing. Lee's Pharmaceutical Limited leads this study, which shows 6 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jul 2019 — Jan 2021 [monthly]

Unknown Status PHASE4

Status: Recruiting → Unknown Status
Jun 2018 — Jul 2019 [monthly]

Recruiting PHASE4

▶ Show 1 earlier version

Sep 2017 — Jun 2018 [monthly]

Recruiting PHASE4

First recorded

Jun 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Lee's Pharmaceutical Limited
Zhaoke Pharmaceutical (Hefei) Company Limited

Data source: Lee's Pharmaceutical Limited

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China